İnflamatuvar Romatizmal Hastalıklar ve Mikrobiyota
Son yıllarda mikrobiyom ve mikrobiyota terimleri sıklıkla kullanılmaktadır. Mikroorganizmalar arası ve mikroorganizma ile konak arasındaki ilişkiler, mikrobiyom çalışmaları ile incelenmektedir. 2007 yılında 300 gönüllü ile başlatılan insan mikrobiyom projesi ile insan vücudundaki tüm mikroorganizmaları belirlemek, insan mikrobiyom değişikliklerinin hastalıklarla ilişkilendirilip ilişkilendirilemeyeceğini araştırmak hedefl enmiştir. İnsan mikrobiyotası; başta bakteriler olmak üzere, virüsler, mantarlar ve birçok ökaryotik mikroorganizmalardan oluşmaktadır. Ayrıca insan vücudundaki bakteri genomu, insan genonumdan 150 kat daha fazladır. Tıpkı genom olarak üstünlükleri gibi, insan vücudundaki mikroorganizma sayısı da insan hücre sayısından 10 kat fazladır. Yani insan, %10 insan ve %90 mikrobiyal hücrelerin birleşiminden oluşan bir holobiont (süperorganizma)’tur. İnsan mikrobiyotasının büyük kısmı, başta sindirim sistemi olmak üzere deri, genitoüriner sistem ve solunum sisteminde kolonize olmuştur. Kolon, tek başına vücudumuzdaki mikroorganizmaların %70’inden fazlasını barındırmaktadır. Mikrobiyotanın insanda, hastalık ve sağlık durumlarında önemli rolü mevcuttur. Bu durumda mikrobiyota, gözardı edilmiş bir organ gibi düşünülebilir. Başta intestinal mikrobiyota olmak üzere insanda mikrobiyota, hastalık ve sağlık durumlarını, bağışıklık hücrelerinin olgunlaşmasını ve bağışıklık sistem fonksiyonlarının normal gelişimini teşvik ederek gerekli sinyalleri sağlar. Mikrobiyota ile ilgili bilimsel veriler romatolojiye yeni bir sayfa açmıştır. Son yıllarda başta bağırsak, ürogenital, solunum yollarının mikrobiyota yapısının inflamatuvar romatizmal hastalıklarla ilişkisi daha çok anlaşılır olmuştur.
Microbiota and Infl ammatory Rheumatic Diseases
In recent years, microbiomic and microbiota terms are frequently used. Relationship between microorganisms and the host can be studied by microbiomic studies. It was aimed to determine by human microbiology project initiated with 300 volunteers in 2007 and to investigate whether human microbiomic changes can be related to diseases. Just like genomics, the number of microorganisms in the human body is 10 times higher than the number of human cells. That is, a human is a holobiont (super organism) consisting of a combination of 10% human and 90% microbial cells. Human microbiota consist of viruses, fungi and many eukaryotic microorganisms, especially bacteria, In addition, the bacterial genome in the human body is 150 times more than the human genome. Most of the human microbiota is colonized in the gut, genitourinary system and respiratory system, especially in the digestive system. The colon alone contains more than 70% of the microorganisms in our body. Microbiota has an important role in human, illness and health. In this case, microbiota can be thought of as an obscured organ. Primarily the intestinal microbiota, provide the necessary signals by promoting immune cell maturation and normal development of immune system functions. Research in microbiota have opened a new page in rheumatology. In recent years, the microbiota structure of the intestines, urogenital, and respiratory tracts has become more understandable in relation to inflammatory rheumatic diseases.
___
- 1. Yılmaz K, Altındiş M. Sindirim sistemi mikrobiyotası ve fekal
transplantasyon. Nobel Med 2017; 13(1):9-15.
- 2. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A,
Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. A core gut
microbiome in obese and lean twins. Nature. 2009;457:480–484.
- 3. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota
in IBD. Nat Rev Gastroenterol Hepatol. 2012;9:599–608.
- 4. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight
R, Gordon JI. The human microbiome project. Nature. 2007;
449:804–10.
- 5. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal
microbiome in infl ammatory bowel disease and treatment. Genome
biology. 2012; 13:R79. [PubMed: 23013615] 22.
- 6. C. Mackay. SP0178 (2017) GUT DYSBIOSIS AND OTHER
CHALLENGES PRECIPITATE ARTHRITIS. Citation: Annals of the
Rheumatic Diseases, volume 76, supplement 2, year 2017, page
43. Session: How diet infl uences musculoskeletal diseases ,
(Speaker Presentations).
- 7. Warden CC. The Toxemic Factor in Rheumatoid Arthritis. Cal State J
Med. 1909; 7:299–301.
- 8. Reis BS, Hoytema van Konijnenburg DP, Grivennikov SI, Mucida
D. Transcription factor T-bet regulates intraepithelial lymphocyte
functional maturation. Immunity. 2014;41:244–256.
- 9. Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the
oral microbiota in new-onset rheumatoid arthritis. Arthritis and
rheumatism. 2012; 64:3083–94.
- 10. Demoruelle MK, Weisman MH, Simonian PL, et al. Brief
report: airways abnormalities and rheumatoid arthritis-related
autoantibodies in subjects without arthritis: early injury or initiating
site of autoimmunity? Arthritis and rheumatism. 2012; 64:1756–
61.
- 11. Kohashi O, Kohashi Y, Takahashi T, Ozawa A, Shigematsu N.
Reverse effect of gram-positive bacteria vs. gram-negative bacteria
on adjuvant-induced arthritis in germfree rats. Microbiol Immunol.
1985; 29:487–97.
- 12. Caccese RG, Zimmerman JL, Carlson RP. Bacterial lipopolysaccharide
potentiates type II collagen-induced arthritis in mice. Mediators of
infl ammation. 1992; 1:273–9.
- 13. Gomez A, Luckey D, Yeoman CJ, et al. Loss of sex and age driven
differences in the gut microbiome characterize arthritis-susceptible
0401 mice but not arthritis-resistant 0402 mice. PloS one. 2012;
7:e36095.
- 14. Eerola E, Mottonen T, Hannonen P, et al. Intestinal fl ora in early
rheumatoid arthritis. Br J Rheumatol. 1994; 33:1030–8.
- 15. Stoll ML. Gut microbes, immunity and spondylarthritis. Clin
Immunol. 2015 Aug;159(2):134-42.
- 16. Arvikar SL, Fisher MC. Infl ammatory bowel disease associated
arthropathy. Current reviews in musculoskeletal medicine. 2011;
4:123–31.
- 17. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD.
Spontaneous infl ammatory disease in transgenic rats expressing
HLA-B27 and human beta 2m: an animal model of HLAB27associated
human disorders. Cell. 1990; 63:1099–112.
- 18. Glatigny S, Fert I, Blaton MA, et al. Proinfl ammatory Th17 cells
are expanded and induced by dendritic cells in spondylarthritisprone
HLA-B27-transgenic rats. Arthritis and rheumatism. 2012;
64:110–20.
- 19. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Jr, Balish
E, Taurog JD, Hammer RE, Wilson KH, Sartor RB. Normal luminal
bacteria, especially Bacteroides species, mediate chronic colitis,
gastritis, and arthritis in HLA-B27/human beta2 microglobulin
transgenic rats. J Clin Invest. 1996;98:945–953.
- 20. Van Praet L, Van den Bosch FE, Jacques P, et al. Microscopic gut
infl ammation in axial spondyloarthritis: a multiparametric predictive
model. Annals of the rheumatic diseases. 2013; 72:414–7).
- 21. Stoll ML, Kumar R, Morrow CD, et al. Altered microbiota associated
with abnormal humoral immune responses to commensal
organisms in enthesitis-related arthritis. Arthritis research &
therapy. 2014; 16:486).
- 22. Stebbings S, Munro K, Simon MA, Tannock G, Highton J, Harmsen
H, Welling G, Seksik P, Dore J, Grame G, et al. Comparison of
the faecal microfl ora of patients with ankylosing spondylitis and
controls using molecular methods of analysis. Rheumatology
(Oxford) 2002;41:1395–1401.].
- 23. Singh YP, Singh AK, Aggarwal A, Misra R. Evidence of cellular
immune response to outer membrane protein of Salmonella
typhimurium in patients with enthesitis-related arthritis subtype of
juvenile idiopathic arthritis. J Rheumatol. 2011;38:161–166.
- 24. Gill T, Asquith M, Rosenbaum JT, Colbert RA. The intestinal
microbiome in spondyloarthritis. Curr Opin Rheumatol. 2015
Jul;27(4):319-25).
- 25. Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity
characterizes the altered gut microbiota in patients with psoriatic
arthritis, resembling dysbiosis in infl ammatory bowel disease.
Arthritis & rheumatology. 2015; 67:128–39.
- 26. Dethlefsen L, Relman DA. Incomplete recovery and individualized
responses of the human distal gut microbiota to repeated antibiotic
perturbation. Proceedings of the National Academy of Sciences of
the United States of America. 2011; 108(Suppl 1):4554–61.).
- 27. Hoentjen F, Welling GW, Harmsen HJ, Zhang X, Snart J, Tannock
GW, Lien K, Churchill TA, Lupicki M, Dieleman LA. Reduction of
colitis by prebiotics in HLA-B27 transgenic rats is associated with
microfl ora changes and immunomodulation. Infl amm Bowel Dis.
2005;11:977–985.].
- 28. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of
donor feces for recurrent Clostridium diffi cile. The New England
journal of medicine. 2013; 368:407–15.
- 29. (Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy
for infl ammatory bowel disease: a systematic review and metaanalysis.
Journal of Crohn’s & colitis. 2014; 8:1569–81.